Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • pharma news

    Tag: pharma news

    You Searched For "pharma news"
    Zydus Cadila gets tentative USFDA nod for Mirabegron ER tablets to treat overactive bladder

    Zydus Cadila gets tentative USFDA nod for Mirabegron ER tablets to treat overactive bladder

    Farhat Nasim2 April 2019 11:50 AM IST
    The company has received tentative approval from the United States Food and Drug Administration (USFDA) to market generic Mirabegron extended-release...
    Novartis to pay $310 million for assets from inflammation specialist IFM

    Novartis to pay $310 million for assets from inflammation specialist IFM

    Garima2 April 2019 9:00 AM IST
    IFM, whose research head Martin Seidel spent more than a decade at Novartis before assuming R&D duties at IFM in 2017, focuses on immune system...
    Cipla gets 8 USFDA observations for Kurkumbh plant

    Cipla gets 8 USFDA observations for Kurkumbh plant

    Farhat Nasim1 April 2019 9:55 AM IST
    The inspection covered three units at the plant. Post the conclusion of the inspection, the company received 8 GMP observations. The company also...
    Lupin, Aurobindo Pharma recalls multiple lots of BP drug including VALSARTAN

    Lupin, Aurobindo Pharma recalls multiple lots of BP drug including VALSARTAN

    Farhat Nasim1 April 2019 9:50 AM IST
    Aurobindo Pharma is also recalling certain lots of Amlodipine and Valsartan Tablets USP 10mg/160mg in 30 count bottles for CGMP deviations.New Delhi:...
    Diabetes Treatment: CDSCO expert panel marketing authorization Nod to Glenmark

    Diabetes Treatment: CDSCO expert panel marketing authorization Nod to Glenmark's SGLT2 Inhibitor Remogliflozin etabonate

    Meghna A Singhania31 March 2019 1:39 PM IST
    New Delhi: Mumbai-based Glenmark Pharmaceuticals Limited recently received the permission from the IND Committee of the Central Drugs Standard...
    USFDA inspected Goa facility, no observations issued: Indoco Remedies

    USFDA inspected Goa facility, no observations issued: Indoco Remedies

    Farhat Nasim30 March 2019 11:52 AM IST
    The US Food and Drug Administration (USFDA) has cleared the Goa-based sterile manufacturing facility of Indoco Remedies for finished dosages.New...
    Unichem Labs gets USFDA approval for Tadalafil Tablets

    Unichem Labs gets USFDA approval for Tadalafil Tablets

    Farhat Nasim30 March 2019 9:30 AM IST
    Tadalafil tablets are a generic version of Eli Lilly's Cialis tablets. The drug is indicated for the treatment of erectile dysfunction (ED), the signs...
    Cancer Causing Talcum Powder: JnJ gets New Jersey jury relief

    Cancer Causing Talcum Powder: JnJ gets New Jersey jury relief

    Medical Dialogues Bureau29 March 2019 11:40 AM IST
    JnJ on Wednesday also settled three other mesothelioma talc cases pending in state courts in California, Oklahoma and New York, Chris Panatier, a...
    Suven Life Sciences secures Product Patent in Brazil, Eurasia

    Suven Life Sciences secures Product Patent in Brazil, Eurasia

    Garima29 March 2019 9:40 AM IST
    The granted claims of patents are being developed as therapeutic agents useful in treatment of cognitive impairment associated with neurodegenerative...
    AstraZeneca, Daiichi Sankyo sign $6.9 billion cancer drug deal

    AstraZeneca, Daiichi Sankyo sign $6.9 billion cancer drug deal

    Garima29 March 2019 9:15 AM IST
    Under the deal, AstraZeneca will pay Daiichi up to $6.9 billion, including a $1.35 billion upfront payment. The two companies will share development...
    Dr Reddy

    Dr Reddy's launches Tadalafil Tablets to treat erectile dysfunction

    Farhat Nasim28 March 2019 12:06 PM IST
    Dr Reddy's Tadalafil tablets are available in four strengths including 2.5 mg, 5 mg, 10 mg, and 20 mg, each in 30-count bottle size.New Delhi: Dr...
    AstraZeneca gets EU nod to diabetes drug Forxiga

    AstraZeneca gets EU nod to diabetes drug Forxiga

    Medical Dialogues Bureau27 March 2019 2:55 PM IST
    Farxiga or Forxiga, as the drug is known outside the United States, is one of AstraZeneca's top ten drugs by sales. It generated $1.39 billion in 2018...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok